Drug interactions between omeprazole and famotidine
Pro Research Analysisby 
Searched over 200M research papers
Drug Interaction Mechanisms: Omeprazole and Famotidine
Omeprazole is a proton pump inhibitor (PPI) and famotidine is a histamine H2-receptor antagonist. Both drugs reduce stomach acid but act through different mechanisms. Omeprazole blocks the final step of acid secretion by inhibiting the H+/K+ ATPase enzyme, while famotidine blocks histamine-induced acid secretion at the H2 receptor level. Studies show that omeprazole directly inhibits the H+/K+ ATPase, whereas famotidine does not, but both can effectively reduce gastric acid secretion when used alone or together .
Clinical Efficacy and Safety of Combined Use
Research indicates that combining omeprazole and famotidine can provide more rapid and sustained acid suppression than either drug alone. The combination leads to a faster increase in gastric pH and maintains higher pH levels over time, which can be beneficial for conditions requiring prompt acid control . Clinical studies in patients with chronic gastritis and reflux esophagitis show that the combination therapy is more effective and has fewer adverse reactions compared to monotherapy with either drug Qunfen2014Shaevitz2021.
Pharmacokinetic Drug Interactions
Omeprazole, but not famotidine, can interact with other drugs metabolized by liver enzymes such as CYP3A4 and CYP2C19. For example, omeprazole increases blood levels of tacrolimus, an immunosuppressant, due to its effect on these enzymes, while famotidine does not have this effect, making famotidine a safer choice for patients on tacrolimus . Additionally, omeprazole can increase plasma levels of methotrexate by inhibiting its elimination via the organic anion transporter 3 (OAT3), whereas famotidine does not significantly affect methotrexate elimination .
Adverse Effects and Special Considerations
Both omeprazole and famotidine are generally well tolerated, but omeprazole may be associated with a slightly higher rate of mild adverse reactions compared to famotidine . In animal studies, both drugs increased the risk of gastrointestinal adverse events when used with NSAIDs, but omeprazole was associated with more frequent and severe events than famotidine . In patients with heart failure, famotidine (but not omeprazole) was found to reduce cardiac output, suggesting that omeprazole may be preferable in this population .
Conclusion
Omeprazole and famotidine can be safely used together for enhanced acid suppression, with clinical studies supporting their combined efficacy and safety in treating acid-related disorders. However, omeprazole has a higher potential for drug-drug interactions, especially with medications metabolized by CYP enzymes or eliminated via OAT3. Famotidine is less likely to cause such interactions and may be preferred in patients taking drugs like tacrolimus or methotrexate. Overall, the combination is effective, but individual patient factors and potential interactions should guide therapy choices An2005Halabi1992Narumi2017+5 MORE.
Sources and full results
Most relevant research papers on this topic